Dr. Angelo Antonini, Dr. Matteo Bologna, Roy Jones, Dr. Fidias Leon-Sarmiento, and Dr. Fabrizio Stocchi, will assist information firm as they advance central nervous system analysis
Blinkcns Scientific Advisory Board
World’s main minds in central nervous system illness have joined the blinkcns scientific advisory board
CHARLESTON, S.C. – March 31, 2021 – (Newswire.com)
Blinkcns, Inc, a biotechnology firm pioneering blink reflex know-how meant to enhance the detection, differentiation, and administration of neurological illness and circumstances, introduced immediately that they’ve appointed 5 new Key Opinion Leaders (KOLs) to their scientific advisory board.
The KOLs will lend their experience to assist steer the corporate’s analysis of ailments and circumstances of the central nervous system (CNS) reminiscent of Parkinson’s Illness, Alzheimer’s Illness/Dementia and Migraine, and the function that the blink reflex could play within the early detection and administration of every.
The brand new KOLs are revered business leaders together with:
- Angelo Antonini, MD, PhD, Director of the Parkinson’s Dept. on the Institute of Neurology, IRCCS San Camillo, Venice;
- Matteo Bologna, MD, PhD, Researcher at Sapienza College of Rome Division of Neurology and Psychiatry in Rome, Italy;
- Roy Jones, BSc (Hons), MBBS, Dip Pharm Med, Professor of Scientific Gerontology & Director at The Analysis Institute for the Care of the Aged in Bathtub, England;
- Fidias Leon-Sarmiento, MD, PhD, Senior analysis investigator on the College of Pennsylvania’s Perelman College of Drugs in State School, Pennsylvania; and
- Fabrizio Stocchi, MD, PhD, Director of the Parkinson’s Illness and Motion Issues Analysis Centre in Rome, Italy;
Angelo Antonini, MD, PhD, is Professor of Neurology and Director of the Parkinson Division on the Institute of Neurology, IRCCS San Camillo in Venice. His analysis focuses on pharmacology of dopaminergic drugs, neuroimaging in addition to cognitive and behavioral points of Parkinson’s illness. Throughout his educational profession, he has revealed nearly 200 peer-reviewed manuscripts and several other e book chapters. He serves as reviewer for the principle neurology journals and has served on the editorial board of Motion Issues in addition to in a number of committees of the Motion Issues Society.
Matteo Bologna, MD, PhD, is Researcher at Sapienza College of Rome within the Division of Neurology and Psychiatry. Dr. Matteo Bologna began a Neurology Residency on the Division of Neurology and Psychiatry at Sapienza College of Rome, Italy. He then joined the Sobell Division of Motor Neuroscience & Motion Issues on the College School of London. His analysis actions mix each neurophysiological and kinematic methods and scientific points associated to the sphere of Motion Issues, significantly Parkinson’s Illness.
Roy Jones, BSc (Hons), MBBS, Dip Pharm Med is the Director at The Analysis Institute for the Care of the Aged, an Honorary Advisor Geriatrician in Bathtub, England and an Honorary Professor at each the College of Bathtub and the College of Bristol. He’s additionally the Dementia Specialty Lead for the NHS West of England Scientific Analysis Community.
Fidias Leon-Sarmiento, MD, PhD is a senior analysis investigator on the College of Pennsylvania’s Perelman College of Drugs. He began this place after receiving coaching in motion issues on the Nationwide Institutes of Well being and acquiring a PhD in neurophysiology from Kagoshina College, Japan. A lot of his present analysis focuses on mind system perform, significantly brainstem and spinal twine reflexes. He’s the creator or co-author of greater than 200 peer-reviewed publications and has acquired quite a few awards for his scientific achievements, together with a number of awards from worldwide establishments.
“The elicitation of the blink reflex has turn into a key factor to deeply assess the perform and dysfunction of the nervous system,” mentioned Dr. Leon. “Having studied the blink reflex and its neural circuits utilizing completely different scientific approaches for greater than 30 years, I discovered EyeStat findings extraordinarily engaging. A number of points of EyeStat attracted me to supporting its use within the clinic; not solely is it transportable, light-weight and straightforward to deal with, nevertheless it’s non-invasive to the affected person and does not convey on a cognitive load like many different applied sciences do. Blinkcns’ know-how has confirmed to acquire quick, goal, and quantitative metrics of a human blink reflex that can fill the hole current for hundreds of years within the medical analysis of issues having scientific and subclinical blink reflex alterations.”
Fabrizio Stocchi, MD, PhD is Professor of Neurology, Advisor in Neurology, and Director of the Parkinson’s Illness and Motion Issues Analysis Centre on the Institute for Analysis and Medical Care IRCCS San Raffaele, Rome and Sapienza College of Rome, Italy. He’s additionally the Scientific Advisor of the Institute for Parkinson’s Illness Analysis in Vicenza. Dr. Stocchi’s analysis actions have centered on neuropharmacology within the area of motion issues and neurodegenerative ailments. He has revealed many books and papers on the genetics, scientific prognosis, characterization and remedy of Parkinson’s Illness, in addition to in preclinical analysis into the illness.
“We’re honored so as to add a few of the world’s main minds in ailments of the central nervous system to the scientific advisory board,” mentioned blinkcns CEO, Jeff Riley. “These consultants convey many years of unmatched expertise in our important analysis areas that can show to be important for the development of our scientific analysis and improvement, research design and implementation, and know-how. We’re proud to name upon these revered thought leaders to assist present scientific strategic course and function advocates of our firm.”
Blinkcns is a biotechnology firm devoted to bettering the detection, differentiation, and administration of neurological illness by way of fast, noninvasive assortment of goal information from the eyes. Blinkcns has the world’s first FDA-cleared patented system, known as EyeStat, that gives quick, goal information in regards to the blink reflex, a element of the startle response. EyeStat deploys eight gentle puffs of air throughout a affected person’s eyelashes to stimulate their blink reflex in a 30-second check. The system makes use of high-speed videography to seize and file the eyelids and measure 10 physiological parameters of the blink reflex utilizing a proprietary algorithm. Blinkcns continues to analysis and apply its know-how to a number of neurological states and circumstances reminiscent of Parkinson’s Illness, Alzheimer’s Illness / Dementia, and Migraine.
E mail: firstname.lastname@example.org
Web site: www.blinkcns.com
Press Launch Service